Regulus Therapeutics Inc. 4
4 · Regulus Therapeutics Inc. · Filed Oct 7, 2016
Insider Transaction Report
Form 4
GRINT PAUL C
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2016-10-05+186,640→ 186,640 totalExercise: $3.52Exp: 2026-10-04→ Common Stock (186,640 underlying)
Footnotes (1)
- [F1]25% of the shares vest on October 5, 2017 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that the option is fully vested on October 5, 2021.